Thirty-four patients with tumor stages III and IV MBC were recruited for analysis of CTCs and DTCs at Shanghai General Hospital from September 2015 to April 2017. Metastasis sites were determined by computed tomography, magnetic resonance imaging, and bone scintigraphy. TNM (Tumor-Node-Metastasis) staging was assessed and given according to the Union for International Cancer Control 2009 guidelines. Patients were followed up until January 2018.

Note: The content above has been extracted from a research article, so it may not display correctly.

Please log in to submit your questions online.
Your question will be posted on the Bio-101 website. We will send your questions to the authors of this protocol and Bio-protocol community members who are experienced with this method. you will be informed using the email address associated with your Bio-protocol account.

We use cookies on this site to enhance your user experience. By using our website, you are agreeing to allow the storage of cookies on your computer.